Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07276347 · ClinicalTrials.gov registry record · NA
Comprehensive Assessment of Multiple Products (CAMP)
A NA study of Myopia and Hyperopia, sponsored by CooperVision International Limited (CVIL).
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT07276347: Recruiting NA study of Myopia and Hyperopia, sponsored by CooperVision International Limited (CVIL).
NCT07276347 is a NA study of Myopia and Hyperopia that is actively recruiting participants, run by CooperVision International Limited (CVIL). The registered enrollment target is 250 participants, roughly in line with the 265-participant average among 90 other Myopia trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07276347, a NA study of Myopia and Hyperopia, is actively recruiting participants, sponsored by CooperVision International Limited (CVIL).
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to assess contact lens performance and acceptance.
Primary Outcome
High contrast, high luminance binocular distance visual acuity (logMAR) will be measured at 10-hour visit.
Interventions
- DEVICE somofilcon A lens
- DEVICE stenfilcon A lens
- DEVICE fanfilcon A lens
- DEVICE comfilcon A lens
- DEVICE verofilcon A lens
Study Locations (1)
Indiana
- Indiana University - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2025-12 |
| Est. Completion | 2026-09 |
| Phase | NA |
What NCT07276347 shows while recruiting
NCT07276347 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 265-participant average among 90 other Myopia trials with a reported enrollment target.
The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 5 interventions - of which somofilcon A lens is the first listed.
NCT07276347 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT07276347 about?
NCT07276347 is a clinical study titled "Comprehensive Assessment of Multiple Products (CAMP)". The aim of this study is to assess contact lens performance and acceptance.
What is the current status of trial NCT07276347?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2025-12. Estimated completion is 2026-09.
What conditions does trial NCT07276347 study?
This clinical trial studies the following conditions: Myopia, Hyperopia.
What interventions are being tested in trial NCT07276347?
The interventions under investigation include: somofilcon A lens (DEVICE), stenfilcon A lens (DEVICE), fanfilcon A lens (DEVICE), comfilcon A lens (DEVICE), verofilcon A lens (DEVICE).
Who is sponsoring clinical trial NCT07276347?
This trial is sponsored by CooperVision International Limited (CVIL), which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07276347 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07276347's enrollment target sits among peer trials
250 20th of 90 higher than 71 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia